ArticleInvestigational new drugs2020

Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3.

Jingjie Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.